A 70-year-old woman with a history of osteoporosis and previous vertebral fracture is reviewed. She has been taking alendronic acid 70mg once weekly for 5 years. Her renal function is eGFR 55 ml/min/1.73m2. She has had no new fractures in the last 3 years. What is the most appropriate management regarding her bisphosphonate therapy?